Pharmaceutical composition comprising entracapone, levodopa, and carbidopa

   
   

An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.

Een mondeling vast lichaam bevestigde dosissamenstelling farmacologisch bestaand uit efficiënte hoeveelheden entacapone, levodopa, en carbidopa, of farmaceutisch aanvaardbare zouten of hydraten daarvan, en farmaceutisch bestaand minstens uit één aanvaardbare vulstof. De samenstelling kan, b.v., voor de behandeling van de ziekte van Parkinson worden gebruikt.

 
Web www.patentalert.com

< Use of intracellular calcium chelators to increase surfactant secretion in the lungs

< Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans

> Compositions and methods for treating ileus

> Fragments of CR1 and their use

~ 00134